((2R,3S,4R,5R)-5-(6-Amino-2-fluoro-9H-purin-9-yl)-3,4-dihydroxytetrahydrofuran-2-yl)methyl dihydrogen phosphate

Catalog No. :
ACICEZ302
CAS No. :
1492-60-0
Molecular Formula :
C10H13FN5O7P
Molecular Weight :
365.21

IUPAC Name:((2R,3S,4R,5R)-5-(6-amino-2-fluoro-9H-purin-9-yl)-3,4-dihydroxytetrahydrofuran-2-yl)methyl dihydrogen phosphate

((2R,3S,4R,5R)-5-(6-Amino-2-fluoro-9H-purin-9-yl)-3,4-dihydroxytetrahydrofuran-2-yl)methyl dihydrogen phosphate structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
No pack options available.

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name((2R,3S,4R,5R)-5-(6-Amino-2-fluoro-9H-purin-9-yl)-3,4-dihydroxytetrahydrofuran-2-yl)methyl dihydrogen phosphate
IUPAC Name((2R,3S,4R,5R)-5-(6-amino-2-fluoro-9H-purin-9-yl)-3,4-dihydroxytetrahydrofuran-2-yl)methyl dihydrogen phosphate
Molecular FormulaC10H13FN5O7P
Molecular Weight365.21
SMILESO=P(O)(OC[C@H]1O[C@@H](N2C=NC3=C(N)N=C(F)N=C23)[C@H](O)[C@@H]1O)O
InChI KeyGIUYCYHIANZCFB-UUOKFMHZSA-N
Synonym5'-Adenylic acid, 2-fluoro-;2-FLUORO-5;2-Fluoro-AMP;2-Fluoroadenosine monophosphate;[(2R,3S,4R,5R)-5-(6-amino-2-fluoropurin-9-yl)-3,4-dihydroxyoxolan-2-yl]methyl dihydrogen phosphate;2-Fluoro-5’-adenylic Acid;2-Fluoroadenosine 5-(dihydrogen phosphate);5-Adenylic acid, 2-fluoro-2-Fluoro-AMP
CAS No.1492-60-0

Synthetic Route by SureRoute

1. ACICEZ302 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACAYOL972 route compound structure diagram
    ACAYOL97210060-13-6 In Stock
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACICEZ302 route product structure diagram
    ACICEZ3021492-60-0
Inquiry

2. ACICEZ302 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACICEZ302 route product structure diagram
    ACICEZ3021492-60-0
Inquiry

Comments (0)